Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-065041
Filing Date
2021-11-17
Accepted
2021-11-17 15:27:36
Documents
1
Period of Report
2021-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13717
  Complete submission text file 0001209191-21-065041.txt   15089
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Issuer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2223 AVENIDA DE LA PLAYA, SUITE 105 LA JOLLA CA 92037
Business Address
Zedelmayer Christine (Reporting) CIK: 0001797818 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38692 | Film No.: 211420455